Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohorts.
Kang X, Lin Z, Calikusu FZ, Miller LA, Soriano S, Locascio JJ, Corvol JC, Maple-Grødem J, Fan Y, Mead K, Campbell MC, Elbaz A, Lesage S, Brice A, Hung AY, Schwarzschild MA, Hayes MT, Wills AM, Herrington TM, Liu G, Ravina B, Taba P, Kõks S, Simuni T, Forsgren L, Counsell C, Macleod AD, Beach TG, Alves G, Tysnes OB, Perlmutter JS, Heutink P, Kasten M, Mollenhauer B, Trenkwalder C, Klein C, Hepp DH, Backstrom D, Svenningsson P, Hu MT, Williams-Gray CH, Barker RA; International Genetics of Parkinson Disease Progression (IGPP) Consortium; Scherzer CR.
Kang X, et al. Among authors: svenningsson p.
NPJ Parkinsons Dis. 2026 May 14. doi: 10.1038/s41531-026-01367-y. Online ahead of print.
NPJ Parkinsons Dis. 2026.
PMID: 42135313
Free article.